journal article·2016-06

Mesoporous Silica as Nanoreactors to Prepare Gd‐Encapsulated Carbon Dots of Controllable Sizes and Magnetic Properties

Hongmin Chen, Geoffrey D. Wang, Xilin Sun, Trever Todd, Fan Zhang, Jin Xie, Baozhong Shen

Advanced Functional Materials· Volume 26· Issue 22
Publisher page

Abstract

Gd‐encapsulated carbonaceous dots (Gd@C‐dots) hold great potential in clinical applications as a novel type of T1 contrast agent for magnetic resonance imaging (MRI). However, current synthetic methods require multiple purification steps due to poor size control, making them unsuitable for high throughput. Herein, a novel, mesoporous silica nanoparticle (MSN)‐templated method for the size‐controlled synthesis of Gd@C‐dots is reported. Briefly, MSNs nanoreactors of different pore sizes are loaded with Gd precursors. Upon calcination, carbon layers are grown around the Gd cations. The spatial restraint of the silica cavity facilitates size control of the produced Gd@C‐dots. Specifically, using 3, 7, and 11 nm MSNs as templates allows the synthesis of 3.0, 7.4, and 9.6 nm Gd@C‐dots, respectively. A significant size impact on the magnetic and optical properties of the nanoparticles is shown, with the smallest Gd@C‐dots showing the highest r1 relaxivity (10 mM−1 s−1) and fluorescence quantum yield (30.2%). The 3.0‐nm Gd@C‐dots were then conjugated with a tumor‐targeting ligand, c(RGDyK), and injected into U87MG xenograft tumor models. Good tumor targeting was observed in T1‐weighted MRI images; whereby the unbound nanoparticles were efficiently excreted through renal clearance, avoiding long‐term toxicity to the host.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Carbon and Quantum Dots Applications · Nanocluster Synthesis and Applications · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Molecular Imaging Center Department of Radiology Fourth Affiliated Hospital Harbin Medical University Harbin Heilongjiang P. R. China

Department of Chemistry and Bio‐Imaging Research Center The University of Georgia Athens Georgia 30602 USA

Center for Molecular Imaging and Translational Medicine State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics School of Public Health Xiamen University Xiamen P. R. China

Funding

National Natural Science Foundation of China

References (59)

Show source-provided references
1. 10.1002/adma.20080236610.1002/adma.200802366 ↗
2. 10.1016/j.mser.2013.03.00110.1016/j.mser.2013.03.001 ↗
3. 10.1002/jmri.2113510.1002/jmri.21135 ↗
4. 10.1002/wnan.119810.1002/wnan.1198 ↗
5. 10.1002/wnan.124310.1002/wnan.1243 ↗
6. 10.3324/haematol.2009.01018110.3324/haematol.2009.010181 ↗
7. 10.2215/CJN.0658090910.2215/CJN.06580909 ↗
8. 10.1021/cr100025t10.1021/cr100025t ↗
9. 10.1021/ja068356j10.1021/ja068356j ↗
10. 10.1002/smll.20130019810.1002/smll.201300198 ↗
11. 10.1002/adma.20120316910.1002/adma.201203169 ↗
12. 10.1016/j.biomaterials.2013.05.06910.1016/j.biomaterials.2013.05.069 ↗
13. 10.1002/adfm.20130243310.1002/adfm.201302433 ↗
14. 10.1021/acsnano.5b0055210.1021/acsnano.5b00552 ↗
15. 10.1002/adma.20140296410.1002/adma.201402964 ↗
16. 10.1021/ja108409510.1021/ja1084095 ↗
17. 10.1002/cmmi.156810.1002/cmmi.1568 ↗
18. 10.1039/c3tb00018d10.1039/c3tb00018d ↗
19. 10.1039/C4TC00988F10.1039/C4TC00988F ↗
20. 10.1002/smll.20110105510.1002/smll.201101055 ↗
21. 10.7150/thno.666810.7150/thno.6668 ↗
22. 10.1021/nn901398j10.1021/nn901398j ↗
23. 10.1021/mp500006z10.1021/mp500006z ↗
24. 10.1021/la204981b10.1021/la204981b ↗
25. 10.1021/la204913t10.1021/la204913t ↗
26. 10.1002/adfm.20100227910.1002/adfm.201002279 ↗
27. 10.1038/srep0147310.1038/srep01473 ↗
28. 10.1021/cr980440x10.1021/cr980440x ↗
29. 10.1038/nrm282010.1038/nrm2820 ↗
30. 10.1002/cmmi.11010.1002/cmmi.110 ↗
31. 10.1002/anie.20070070010.1002/anie.200700700 ↗
32. 10.1039/c2cc30757j10.1039/c2cc30757j ↗
33. 10.1002/jmri.188008032810.1002/jmri.1880080328 ↗
34. 10.1007/s11095-010-0131-910.1007/s11095-010-0131-9 ↗
35. 10.1002/jmri.2196910.1002/jmri.21969 ↗
36. 10.1038/nprot.2007.10710.1038/nprot.2007.107 ↗
37. 10.7150/thno/v01p010210.7150/thno/v01p0102 ↗
38. 10.1039/C4CS00269E10.1039/C4CS00269E ↗
39. 10.1039/C4NR05712K10.1039/C4NR05712K ↗
40. 10.1021/ja904843x10.1021/ja904843x ↗
41. 10.1021/ja062677d10.1021/ja062677d ↗
42. 10.1002/adma.20157017110.1002/adma.201570171 ↗
43. 10.1021/acsami.5b0485110.1021/acsami.5b04851 ↗
44. 10.1021/bc900051d10.1021/bc900051d ↗
45. 10.1021/ja034098410.1021/ja0340984 ↗
46. 10.1021/jp070458o10.1021/jp070458o ↗
47. 10.1039/b504435a10.1039/b504435a ↗
48. Sithararnan B. · Int. J. Nanomed. · 2006 · 1 · 291
49. 10.1002/adfm.20120149910.1002/adfm.201201499 ↗
50. 10.1002/adma.20130023310.1002/adma.201300233 ↗
51. 10.1021/ja904843x10.1021/ja904843x ↗
52. 10.1002/adma.20090282510.1002/adma.200902825 ↗
53. 10.1002/adfm.20120344110.1002/adfm.201203441 ↗
54. 10.1021/jp807648510.1021/jp8076485 ↗
55. 10.1021/cm900709w10.1021/cm900709w ↗
56. 10.1002/anie.20130111410.1002/anie.201301114 ↗
57. 10.7150/thno.666810.7150/thno.6668 ↗
58. 10.1021/nn101643u10.1021/nn101643u ↗
59. 10.1021/nn305991e10.1021/nn305991e ↗